Babyscripts Forms Commercial Partnership with Roche to Develop RPM Programs for Pregnancy

Babyscripts Forms Commercial Partnership with Roche to Develop RPM Programs for Pregnancy
Babyscripts Forms Commercial Partnership with Roche to Develop RPM Programs for Pregnancy

What You Should Know:  

Babyscripts today announced a commercial partnership with
Roche Diagnostics, a division of the world’s largest biotech company and a
global pioneer in pharmaceuticals and diagnostics. 

– Roche will partner with Babyscripts on the
development of Babyscripts’ remote patient monitoring (RPM) programs to
leverage groundbreaking data science through the next generation of RPM in
pregnancy. 


Babyscripts, a
Washington D.C.-based virtual care platform for managing obstetrics, today
announced a commercial partnership with Roche
Diagnostics
, a division of the world’s largest biotech company and a
global pioneer in pharmaceuticals and diagnostics. Roche Diagnostics and Babyscripts will collaborate on the next generation of
digital and diagnostic combinations in women’s health.

Commercial Partnership to Power Next-Generation of RPM in
Pregnancy

Under the terms of this collaboration,
Roche will partner with Babyscripts on the
development of Babyscripts’ remote patient
monitoring (RPM) programs to leverage groundbreaking data science through the
next generation of RPM in pregnancy. These programs will be focused on solving
issues of blood pressure-related complications through RPM, such as prenatal
hypertension. Babyscripts participated in Startup
Creasphere
, Roche’s digital health accelerator
program, which was instrumental in initiating this collaboration.

Babyscripts Virtual
Care Platform Background

Babyscripts has spent
the last six years building a clinically-validated, virtual care platform to
allow OBGYNs to deliver a new model of prenatal and postpartum care. Using
internet-connected devices for remote monitoring, Babyscripts offers
risk-specific experiences to allow providers to manage up to 90% of pregnancies
virtually, allowing doctors to detect risk more quickly and automate elements
of care.

“Roche’s investment in Babyscripts solutions is a tremendous validation of our vision for improving maternal care, and an example of the kind of strategic collaboration essential to moving the needle on outcomes,” said Juan Pablo Segura, co-founder and President of Babyscripts. “Roche’s vast expertise in the field of women’s health diagnostics and clinical science combined with our on-the-ground experience in the virtual maternal health space is going to prove a game changer for rethinking how we approach prenatal and postpartum care.”

<!–

–>

[ultimatesocial networks=”facebook,twitter,google,linkedin,mail” url=””
custom_class=”us-posts-bottom” align=”left” count=”false”]